Inherited retinal diseases (IRDs) are genetically heterogeneous disorders which is one of the cause of blindness. There are more than 100 types of inherited retinal diseases and severity varies significantly. Due to inherited nature of these disease there is no cure and hence path to the inherited retinal diseases treatment is not clear. Recently in 2018, gene therapy based inherited retinal diseases treatment was approved by FDA.
There are more than 200 DNA which are responsible for this disease further making inherited retinal diseases treatment difficult. Most of children suffering from this disease turn blind within a year after they are born. Around 4 of every 10,000 children born in the UK are diagnosed with some form of inherited retinal disease and the prevalence further increases to 6 per 10,000 in population below aged 16 years. This represent significant amount population though the incidence of the disease seems low, further making inherited retinal diseases treatment important.
The increasing prevalence of the inherited retinal diseases expected to drive the growth of inherited retinal diseases treatment market. Increasing awareness and treatment seeking rate expected to fuel the growth of inherited retinal diseases treatment market. Increasing understanding about the inherited retinal diseases treatment options and diagnosis of the disease further expected to enhance the growth of inherited retinal diseases treatment market. Increasing expenditure R& D by the product manufacturing companies in the inherited retinal diseases treatment market expected to increase revenue generation in near future.
The manufacturing companies in the inherited retinal diseases treatment market further focusing on the gene mutation specific approach for the developing new products further expected to drive the growth of inherited retinal diseases treatment market. Various manufacturers are engaging in the collaborations, partnerships to carry out clinical trials to further develop inherited retinal diseases treatment options more efficiently.
Globally increasing prevalence of the disease expected to contribute to inherited retinal diseases treatment market significantly. By the treatment type inherited retinal diseases treatment market is expected to be dominated by gene therapy treatment. Whereas, by distribution channel inherited retinal diseases treatment market is expected to be dominated by retail pharmacies. The manufacturers in inherited retinal diseases treatment market are highly focusing on the development of new formulation for the inherited retinal diseases treatment.
The global inherited retinal diseases treatment market is expected to be dominated by North America due higher treatment seeking rate and higher penetration of inherited retinal diseases treatment options.
Europe is expected to be the second most lucrative inherited retinal diseases treatment market due to comparatively higher prevalence of inherited retinal diseases coupled with higher treatment seeking rate. Asia-Pacific is expected to be the fastest growing inherited retinal diseases treatment market due to rapidly increasing awareness about the disease and increasing product penetration in the region. Presence of one of the fastest growing economies such as India and China further expected drive the growth of inherited retinal diseases treatment market in the APAC region.
Latin America inherited retinal diseases treatment market is expected to witness steady growth due to increasing diagnosis of the condition in the region. Middle East and Africa is least lucrative inherited retinal diseases treatment market due to low treatment seeking rate, low product penetration, and low diagnosis rate. Overall, global inherited retinal diseases treatment market expected to witness significant growth due to increasing penetration of products and diagnosis.
Some of the global key participants operating in inherited retinal diseases treatment market are: Spark Therapeutics, Novartis AG, and others
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Inherited retinal diseases treatment market is segmented based on the treatment type, distribution channel, and region
By the treatment type Inherited retinal diseases treatment market is segmented as:
By distribution channel Inherited retinal diseases treatment market is segmented as:
Explore Similar Insights
Inherited Retinal Diseases Treatment Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
